Repligen
RGEN
#2471
Rank
ยฃ5.58 B
Marketcap
ยฃ99.07
Share price
-4.10%
Change (1 day)
9.37%
Change (1 year)
Categories

Repligen (RGEN) - Total assets

Total assets on the balance sheet as of March 2026 : ยฃ2.20 Billion

According to Repligen 's latest financial reports the company's total assets are ยฃ2.20 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Repligen - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31ยฃ2.19 B-2.86%
2024-12-31ยฃ2.25 B1.47%
2023-12-31ยฃ2.22 B6.2%
2022-12-31ยฃ2.09 B19.77%
2021-12-31ยฃ1.74 B25.15%
2020-12-31ยฃ1.39 B30.75%
2019-12-31ยฃ1.06 B74.97%
2018-12-31ยฃ0.61 B10.93%
2017-12-31ยฃ0.55 B134.96%
2016-12-31ยฃ0.23 B137.28%
2015-12-31ยฃ98.68 M19.75%
2014-12-31ยฃ82.4 M14.56%
2013-12-31ยฃ71.92 M19.84%
2012-12-31ยฃ60.02 M
2011-03-31ยฃ45.08 M-3.46%
2010-03-31ยฃ46.7 M-8.43%
2009-03-31ยฃ51 M48.83%
2008-03-31ยฃ34.26 M131.32%
2007-03-31ยฃ14.81 M-10.47%
2006-03-31ยฃ16.54 M12.93%
2005-03-31ยฃ14.65 M-8.14%
2004-03-31ยฃ15.95 M-6.15%
2003-03-31ยฃ16.99 M-16.79%
2002-03-31ยฃ20.42 M-10.09%
2001-03-31ยฃ22.71 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Pfizer
PFE
ยฃ155.86 B 6,984.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
ยฃ85.04 B 3,765.23%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
ยฃ95.84 B 4,256.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
ยฃ64.91 B 2,850.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
ยฃ45.01 M-97.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
ยฃ0.78 B-64.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
ยฃ3.68 B 67.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
ยฃ1.91 B-12.97%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
ยฃ6.44 B 193.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
ยฃ5.80 B 163.76%๐Ÿ‡บ๐Ÿ‡ธ USA